Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Poretz

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
The Journal of Antimicrobial Chemotherapy|July 1, 1983
Ceftriaxone therapy of serious bacterial infectionsL J Eron, C H Park, R I Goldenberg, et al.
Southern Medical Journal|July 1, 1983
Piperacillin therapy for Pseudomonas infectionsL J Eron, R I Goldenberg, D M Poretz, et al.
American Journal of Hospital Pharmacy|August 1, 1974
Microbial contamination of glass bottle (open-vented) and plastic bag (closed-nonvented) intravenous fluid delivery systemsD M Poretz, J B Guynn, R J Duma, et al.
The Journal of Antimicrobial Chemotherapy|July 1, 1983
Ceftazidime in patients with Pseudomonas infectionsL J Eron, C H Park, D L Hixon, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1983
Imipenem versus moxalactam in the treatment of serious infectionsL J Eron, D L Hixon, C H Park, et al.
Pediatric Infectious Disease|November 1, 1984
Intravenous antibiotic therapy in ambulatory pediatric patientsR I Goldenberg, D M Poretz, L J Eron, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1983
Ceftriaxone therapy of bone and soft tissue infections in hospital and outpatient settingsL J Eron, C H Park, D L Hixon, et al.
The American Journal of Medicine|October 19, 1984
Outpatient use of ceftriaxone: a cost-benefit analysisD M Poretz, D Woolard, L J Eron, et al.
Virginia Medical|May 1, 1981
Mycobacterium chelonei infects the maxillary sinus: a rare caseL J Eron, C Huckins, C H Park, et al.
JAMA|July 16, 1982
Intravenous antibiotic therapy in an outpatient settingD M Poretz, L J Eron, R I Goldenberg, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
The Journal of Antimicrobial Chemotherapy|July 1, 1983
Ceftriaxone therapy of serious bacterial infectionsL J Eron, C H Park, R I Goldenberg, et al.
Southern Medical Journal|July 1, 1983
Piperacillin therapy for Pseudomonas infectionsL J Eron, R I Goldenberg, D M Poretz, et al.
American Journal of Hospital Pharmacy|August 1, 1974
Microbial contamination of glass bottle (open-vented) and plastic bag (closed-nonvented) intravenous fluid delivery systemsD M Poretz, J B Guynn, R J Duma, et al.
The Journal of Antimicrobial Chemotherapy|July 1, 1983
Ceftazidime in patients with Pseudomonas infectionsL J Eron, C H Park, D L Hixon, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1983
Imipenem versus moxalactam in the treatment of serious infectionsL J Eron, D L Hixon, C H Park, et al.
Pediatric Infectious Disease|November 1, 1984
Intravenous antibiotic therapy in ambulatory pediatric patientsR I Goldenberg, D M Poretz, L J Eron, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1983
Ceftriaxone therapy of bone and soft tissue infections in hospital and outpatient settingsL J Eron, C H Park, D L Hixon, et al.
The American Journal of Medicine|October 19, 1984
Outpatient use of ceftriaxone: a cost-benefit analysisD M Poretz, D Woolard, L J Eron, et al.
Virginia Medical|May 1, 1981
Mycobacterium chelonei infects the maxillary sinus: a rare caseL J Eron, C Huckins, C H Park, et al.
JAMA|July 16, 1982
Intravenous antibiotic therapy in an outpatient settingD M Poretz, L J Eron, R I Goldenberg, et al.
Pageof 5